Quest Laboratories Limited (NSE:QUESTLAB)

Market Cap	1.90B +6.3%
Revenue (ttm)	1.26B +61.5%
Net Income	213.89M +220.7%
EPS	9.92 +129.1%
Shares Out	16.39M
PE Ratio	11.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,200
Open	121.50
Previous Close	121.30
Day's Range	115.55 - 121.50
52-Week Range	75.15 - 152.60
Beta	1.23
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Quest Laboratories

Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in contract manufa...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1994
• Employees: 50
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: QUESTLAB

Financial Performance

In fiscal year 2025, Quest Laboratories's revenue was 1.04 billion, an increase of 25.92% compared to the previous year's 825.63 million. Earnings were 135.66 million, an increase of 34.40%.